These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12912710)

  • 1. Benefits of combination therapy of insulin and oral hypoglycemic agents.
    Garber AJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1781-2. PubMed ID: 12912710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy of insulin sensitizer and sulfonylurea].
    Hari J
    Nihon Rinsho; 1997 Nov; 55 Suppl():197-203. PubMed ID: 9434467
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for patients. Comparison of two types of insulin added to diabetes pills in poorly controlled type 2 diabetes.
    Ann Intern Med; 2008 Oct; 149(8):I-46. PubMed ID: 18936498
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [When HbA1c cannot be pushed down under 7. Don't hesitate to use a 2d antidiabetic agent].
    MMW Fortschr Med; 2003 Mar; 145(10):59. PubMed ID: 12688034
    [No Abstract]   [Full Text] [Related]  

  • 6. Course of glycaemia in poorly controlled type 2 diabetes patients 2.5 years after optimizing oral treatment in general practice.
    Berghout LM; Gorter KJ; Rutten GE
    Eur J Gen Pract; 2006; 12(2):80-2. PubMed ID: 16945883
    [No Abstract]   [Full Text] [Related]  

  • 7. [New rank order of antidiabetic drugs. Using glitazone before sulfonylurea drugs? (interview by Dr. Dirk Einecke)].
    Jacob S
    MMW Fortschr Med; 2007 Jan; 149(1-2):14. PubMed ID: 17632857
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program.
    Lawrence DB; Ragucci KR; Long LB; Parris BS; Helfer LA
    J Manag Care Pharm; 2006; 12(6):466-71. PubMed ID: 16925454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensified insulin therapy. Is there an alternative to BE count?].
    MMW Fortschr Med; 2006 Sep; 148(37):21. PubMed ID: 17036898
    [No Abstract]   [Full Text] [Related]  

  • 11. Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?
    Kirk JK; Pearce KA; Michielutte R; Summerson JH
    J Fam Pract; 1999 Nov; 48(11):879-82. PubMed ID: 10907625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen.
    Rendell MS; Glazer NB; Ye Z
    J Diabetes Complications; 2003; 17(4):211-7. PubMed ID: 12810245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
    Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
    Fonseca V; Gill J; Zhou R; Leahy J
    Diabetes Obes Metab; 2011 Sep; 13(9):814-22. PubMed ID: 21481127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Kipnes MS; Krosnick A; Rendell MS; Egan JW; Mathisen AL; Schneider RL
    Am J Med; 2001 Jul; 111(1):10-7. PubMed ID: 11448655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetes.
    Bell DS; Ovalle F
    Diabetes Obes Metab; 2006 Jan; 8(1):110-5. PubMed ID: 16367889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
    Hanefeld M; Fischer S
    MMW Fortschr Med; 2003 Feb; 145(9):30-4. PubMed ID: 12666526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term HbA1c stable. Insulin sensitizer keeps diabetes in check].
    MMW Fortschr Med; 2004 Mar; 146(13):60. PubMed ID: 15219138
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis.
    Goring S; Hawkins N; Wygant G; Roudaut M; Townsend R; Wood I; Barnett AH
    Diabetes Obes Metab; 2014 May; 16(5):433-42. PubMed ID: 24237939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.
    Holman RR; Thorne KI; Farmer AJ; Davies MJ; Keenan JF; Paul S; Levy JC;
    N Engl J Med; 2007 Oct; 357(17):1716-30. PubMed ID: 17890232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.